Qiagen N.V.
Provider of technologies transforming biological materials into molecular insights.
QIA | F
Overview
Corporate Details
- ISIN(s):
- DE000A286LP0 (+5 more)
- LEI:
- 54930036WK3GMCN17Z57
- Country:
- Netherlands
- Address:
- HULSTERWEG 82, 5912 PL VENLO
- Website:
- https://www.qiagen.com/
- Sector:
- Manufacturing
Description
Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-19 19:51 |
6-K
|
English | 145.3 KB | ||
| 2025-11-12 10:33 | English | 11.9 KB | |||
| 2025-11-06 00:00 |
Q3 statement / Q3 financial report 2025
|
English | 896.5 KB | ||
| 2025-11-05 21:59 |
6-K
|
English | 151.3 KB | ||
| 2025-11-05 21:39 |
6-K
|
English | 398.0 KB | ||
| 2025-11-05 12:48 |
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
|
English | 120.2 KB | ||
| 2025-11-05 12:48 |
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
|
English | 366.8 KB | ||
| 2025-11-04 19:02 |
QIAGEN N.V.: QIAGEN announces CEO transition plan
|
English | 6.5 KB | ||
| 2025-09-30 11:25 |
Qiagen N.V., Halfjaarlijkse financiële verslaggeving
|
English | 268.3 KB | ||
| 2025-08-29 20:12 |
6-K
|
English | 245.0 KB | ||
| 2025-08-28 10:07 |
Ad-hoc announcement pursuant to Art. 17 MAR - QIAGEN N.V. launches non-US offer…
|
English | 126.3 KB | ||
| 2025-08-28 07:57 |
QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled converti…
|
English | 18.4 KB | ||
| 2025-08-22 00:00 |
Half-yearly financial report 2025
|
English | 428.1 KB | ||
| 2025-08-21 19:20 |
6-K
|
English | 147.3 KB | ||
| 2025-08-15 18:52 | English | 6.9 KB |
Automate Your Workflow. Get a real-time feed of all Qiagen N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Qiagen N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Qiagen N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-04-17 | S. Rusckowski | Non-Executive member | Other | 26 | N/A |
| 2023-03-14 | E.R. Mardis | Non-Executive member | Sell | 4,739 | 218,422.41 USD |
| 2023-02-28 | E. Pisa | Non-Executive member | Other | 7,917 | N/A |
| 2023-02-21 | R. Sackers | Non-Executive member | Other | 51,500 | N/A |
| 2022-12-01 | R. Sackers | Non-Executive member | Sell | 30,000 | 1,500,000.00 USD |
| 2022-10-31 | M. Colpan | Non-Executive member | Other | 457 | N/A |
| 2022-06-08 | R. Sackers | Non-Executive member | Sell | 32,398 | 1,522,706.00 USD |
| 2022-03-31 | R. Sackers | Non-Executive member | Other | 72,944 | N/A |
| 2022-03-15 | R. Sackers | Non-Executive member | Other | 7,606 | N/A |
| 2022-03-14 | E.R. Mardis | Non-Executive member | Sell | 5,003 | 228,330.77 USD |
Peer Companies
